• MK-571 Workflows for Inflammation Research

  2026-08-17

  MK-571, also called L-660,711, helps separate cysteinyl leukotriene receptor signaling from MRP1/ABCC1 transporter effects. This practical guide shows how to deploy the compound in airway contraction, pulmonary inflammation, barrier, and macrophage cytotoxicity assays while controlling DMSO, timing, and mechanism-specific confounders.

• SN-38 Disrupts FUBP1–FUSE Binding

  2026-08-17

  The reference study identifies an additional activity of camptothecin and SN-38: inhibition of FUBP1 binding to the single-stranded DNA element FUSE. By combining compound-library screening, biochemical binding assays, and cellular gene-expression analyses, the authors propose that interference with FUBP1 may complement the canonical topoisomerase I inhibition pathway in FUBP1-dependent tumors.

• Light-Inducible RNA Release for Gene Therapy

  2026-08-16

  The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic translation by keeping target mRNA functionally repressed in darkness and permitting expression under light. In mouse models, this compact translational switch enabled reversible regulation of metabolic and retinal gene therapies, highlighting a potential safety advantage for treatments requiring on-demand control.

• Norepinephrine–Angiotensin II Conversion in Shock

  2026-08-15

  A post-hoc analysis of the ARAMIS trial estimated a clinically useful norepinephrine-to-angiotensin II conversion ratio in patients with vasodilatory hypotension. The study supports a 10:1 ratio for norepinephrine bitartrate equivalents, while also showing that baseline renin did not materially alter the estimate and prior ARB exposure may reduce it.

• Superoxide Dismutase Activity Assay Kit Guide

  2026-08-14

  The Superoxide Dismutase Activity Assay Kit K2035 provides a rapid colorimetric route to quantify functional SOD activity in biological fluids. Its WST-1 and xanthine oxidase design is especially useful when researchers need an antioxidative enzyme assay that complements, rather than substitutes for, direct hydrogen peroxide measurements.

• p-Cresyl Sulfate Drives Aortic Valve Calcification

  2026-08-14

  The reference study identifies p-Cresyl sulfate as a direct promoter of calcification in aortic valvular interstitial cells and links this effect to HIF-1α activation, klotho loss, and impaired SIRT1-associated signaling. Its cell and rat experiments suggest that klotho supplementation or SIRT1 activation can reduce the NF-κB/RUNX2 response, providing a mechanistic framework for CKD-associated calcific aortic valve disease research.

• Z-VAD-FMK: Mechanism, Evidence, and Workflow

  2026-08-13

  Z-VAD-FMK, also searched as z vad fmk, is a cell-permeable, irreversible pan-caspase inhibitor used for apoptosis inhibition and apoptotic pathway research. It is useful for testing caspase dependence, but it should not be treated as proof that every form of cell death or cancer-associated tissue loss is caspase mediated.

• FPH1 (BRD-6125) Hepatocyte Workflow Guide

  2026-08-13

  FPH1 (BRD-6125) helps connect hepatocyte expansion with functional readouts such as albumin, CYP3A4, AFP, nuclei count, and mitotic activity. This practical guide covers primary human hepatocyte culture, iPS-derived hepatocyte workflows, assay controls, dosing, and troubleshooting without conflating proliferation with maturation.

• NEDD4–ZBTB7B–ADPGK Axis in Lung Adenocarcinoma

  2026-08-12

  This 2026 study identifies a NEDD4/ZBTB7B/ADPGK regulatory axis that connects ubiquitin-mediated protein turnover with glycolytic activation in lung adenocarcinoma. Its findings suggest that measuring proliferation alongside metabolic and molecular endpoints may improve mechanistic evaluation of LUAD models, while clinical translation remains to be established.

• ZCL278: A Selective Cdc42 Inhibitor Workflow

  2026-08-12

  ZCL278 is a selective Cdc42 inhibitor for connecting acute Cdc42 pathway perturbation with measurable changes in motility, neuronal morphology, and fibroblast signaling. This practical workflow covers dosing, controls, biochemical validation, troubleshooting, and responsible interpretation across cell-based research models.

• Lambda Protein Phosphatase for BMAL1 Phosphorylation

  2026-08-11

  BMAL1 phase separation introduces a new mechanistic question for circadian biology: how does phosphorylation tune the formation and function of transcriptional condensates? This thought-leadership guide shows how Lambda Protein Phosphatase (RNase-free) can provide a controlled dephosphorylation axis for antibody validation, phosphorylation site validation, condensate analysis, and translational assay design.

• HyperScript™ Reverse Transcriptase for qPCR

  2026-08-11

  Learn how HyperScript™ Reverse Transcriptase, SKU K1071, can strengthen RNA-to-cDNA conversion when cell viability, proliferation, or cytotoxicity studies require molecular follow-up. This scenario-based guide covers complex RNA structure, low-copy targets, protocol controls, interpretation, and practical vendor selection.

• Trolox C3183 for Reliable Cell Assays

  2026-08-10

  Learn how Trolox (SKU C3183) can serve as a practical antioxidant control in cell viability, cytotoxicity, and oxidative injury workflows. This scenario-based guide covers solvent compatibility, dosing logic, vendor selection, assay interpretation, and the limits of translating antioxidant data across experimental systems.

• Prochlorperazine: From D2 Antagonism to Translation

  2026-08-09

  Prochlorperazine illustrates how an established dopamine D2 receptor antagonist can become a translational research tool across antiemetic therapy, melanoma research, membrane trafficking, and cancer research—provided that receptor biology, assay context, and safety boundaries are interpreted together.

• How Kinase Inhibitors Tune p38α Dephosphorylation

  2026-08-08

  The reference preprint shows that selected kinase inhibitors can do more than block p38α MAP kinase catalysis: they can also expose the activation-loop phospho-threonine to WIP1, accelerating dephosphorylation. Its structural and biochemical results introduce kinase-conformation control as a possible route to more potent and selective pathway inhibition.

16804 records 1/1121 page Next 12345 下5页 Last page